PDS Biotechnology Corp (PDSB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US70465T1079
PDS Biotechnology Corp financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -31.54 m USD |
| EBIT | -31.54 m USD |
| Net income | -34.50 m USD |
| Diluted EPS – continuing operations | -0.74 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PDS Biotechnology Corp
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, Georgia Research Foundation, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
More stocks
- Edge Copper Corporation (EDCU.TO)
- LiveOne, Inc. (LVO)
- Sun Max Tech Ltd (6591.TW)
- Massimo Group (MAMO)
- Instil Bio, Inc. (TIL)
- FUEL TECH, INC. (FTEK)
- Brand X Co. Ltd. (337930.KQ)
- Kaonmedia Co Ltd (078890.KQ)
- Electra Battery Materials Corp (ELBM.V)
- TaiRx, Inc. (6580.TWO)
- Chen Nan Iron Wire Co.,Ltd (2071.TWO)
- Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.